Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment‐resistant depression: A preliminary single‐center retrospective cohort study
Neuropsychopharmacology Reports · 2025
DOI: 10.1002/npr2.12494 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neuropsychopharmacology Reports, 2025. Verfasst von Ami Nakazawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Jikei University School of Medicine, Minato-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant, Lipid Metabolism, Body Mass Index. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Jikei University School of Medicine Women's Researcher Career Support System.
Themen: Depression
Abstract (Originalsprache)
Aim
This study aimed to elucidate the effects of repetitive transcranial magnetic stimulation (rTMS) on weight, body mass index (BMI), and lipid metabolism in patients with treatment‐resistant depression (TRD).
Methods
This retrospective observational study included patients with TRD who received rTMS treatment at the Jikei University Hospital from September 2018 to August 2021. The patients were diagnosed based on the DSM‐5 and ICD‐10 criteria and treated using the NeuroStar TMS System. For 3–6 weeks, 10‐Hz rTMS was administered to the left dorsolateral prefrontal cortex at 120% motor threshold. The primary outcomes were changes in weight and BMI, whereas the secondary outcomes included changes in total, high‐density lipoprotein (HDL), and low‐density lipoprotein (LDL) cholesterol levels, thyroid function indicators, as well as HAMD‐17, HAMD‐24, and Montgomery–Åsberg Depression Rating Scale (MADRS) scores. Statistical analysis was conducted using paired t ‐tests and repeated measures ANOVA.
Results
Among the 34 patients (20 men and 14 women) included, no significant changes were observed in weight or BMI after rTMS treatment (average weight reduction: −0.50 kg, 95% CI: −0.14 to 0.56, p = 0.24; average BMI reduction: −0.21, 95% CI: −0.10 to 0.61, p = 0.15). However, significant reductions in total, HDL, and LDL cholesterol levels and FT4 were observed. Furthermore, the HAMD‐17, HAMD‐24, and MADRS scores significantly increased post‐treatment. Conclusion rTMS treatment did not affect weight or BMI in patients with TRD but is believed to improve lipid metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
- Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Minato-ku, Tokyo, Japan.
ORCID-Profile: Ami Nakazawa
Förderung
- The Jikei University School of Medicine Women's Researcher Career Support System
Zitieren
APA
Nakazawa, A., Matsuda, Y., Yamazaki, R., Taruishi, N., & Kito, S. (2025). Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment‐resistant depression: A preliminary single‐center retrospective cohort study. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12494
Vancouver
Nakazawa A, Matsuda Y, Yamazaki R, Taruishi N, Kito S. Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment‐resistant depression: A preliminary single‐center retrospective cohort study. Neuropsychopharmacology Reports. 2025. doi:10.1002/npr2.12494
BibTeX
@article{Nakazawa2025,
author = {Nakazawa, Ami and Matsuda, Yuki and Yamazaki, Ryuichi and Taruishi, Nanase and Kito, Shinsuke},
title = {Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment‐resistant depression: A preliminary single‐center retrospective cohort study},
journal = {Neuropsychopharmacology Reports},
year = {2025},
doi = {10.1002/npr2.12494}
}
EUVIMED